CARDIOMETABOLIC HEALTH CONGRESS

Diabetes

Digital Education Hubs

Once thought to be purely an endocrine disorder, a more modern understanding of insulin resistance and glycemic regulation has revealed that prediabetes, type 1 and type 2 diabetes are hugely related to cardiometabolic disease and its many comorbidities. As the understanding of how diabetes is related to conditions like obesity and heart failure grows, more therapeutic targets are being identified, showing promise for many new treatments.

News Digest

Expert Highlights and Perspectives

PREDIABETES: SCREENING, DIAGNOSIS, AND MANAGEMENT

(Recorded April 2022)

Leigh Perreault, MD
Leigh Perreault,
MD

DUAL GLP-1/GIP AGONISTS: ARE THEY THE NEXT BIG THING IN DIABETES TREATMENT

(Recorded April 2022)

Athena Philis-Tsimikas,
MD

HOW CAN WE CONVERGE THE GLUCOCENTRIC AND CARDIO-RENAL RISK MANAGEMENT IN DIABETES PATIENTS

(Recorded April 2022)

Lawrence A. Leiter,
MD

THE EVOLUTION OF INSULIN: A 2022 UPDATE

(Recorded April 2022)

Grazia Aleppo,
MD

TECHNOLOGY IN DIABETES BEYOND CGM

(Recorded April 2022)

Steven J. Russell
MD, PhD

PANEL DISCUSSION ON DIABETES TECHNOLOGY: CGM AND BEYOND

(Recorded April 2022)

Steven J. Russell
MD, PhD
Anne L. Peters,
MD
Anne L. Peters,
MD
Leigh Perreault, MD
Leigh Perreault,
MD
Lawrence A. Leiter,
MD
Grazia Aleppo,
MD

PERSPECTIVES ON DIABETES MANAGEMENT

(Recorded April 2022)

Drug Pipeline

Drug Pipeline Coming Soon

#C1E5E9

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

#C1E5E9

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

#C1E5E9

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Resources

American Diabetes Association – 2022 Standards of Medical Care in Diabetes
Diabetes Technology – Standards of Medical Care in Diabetes – 2022
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes – 2022
AACE: 2021 Advances Diabetes Technology Guideline
AHA Scientific Statement: Comprehensive Management of Cardiovascular Risk Factors For Adults with Type 2 Diabetes
Why Should We Use CGM in Patients With Type 2 Diabetes? Assessing the Evidence and Practical Pearls for Integration
CGM Metrics and Interpretation
Features of Available CGM Systems
Personal & Professional CGM Billing
Interfering Substances in CGM Systems

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.